Robin Henson
Family · Prosper, TXNPI 1700035029
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 259 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 36 manufacturers reported payments, led by AbbVie at 32.1% of the total. Reporting peaked in 2021 at $1,076 and has fallen 59.2% since, to $439 in 2025. Among family clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 259 payments — averaging $14.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$380
- Currax Pharmaceuticals LLC$315
- Pfizer$201
- Otsuka America Pharmaceutical, Inc.$135
- Antares Pharma, Inc.$130
- plus $1K from 30 others
What the payments were for
- Food & beverage$3,655100%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 106 | $1,173 |
| Lilly USA, LLC | 24 | $380 |
| Currax Pharmaceuticals LLC | 25 | $315 |
| Pfizer | 13 | $201 |
| Otsuka America Pharmaceutical, Inc. | 6 | $135 |
| Antares Pharma, Inc. | 6 | $130 |
| Johnson & Johnson | 7 | $123 |
| Teva Pharmaceuticals USA, Inc. | 5 | $107 |
| AstraZeneca | 6 | $90 |
| Novo Nordisk | 4 | $81 |
| Biohaven Pharmaceuticals, Inc. | 5 | $80 |
| Axsome Therapeutics, Inc. | 4 | $74 |
| Kowa Pharmaceuticals America, Inc. | 5 | $71 |
| Daiichi Sankyo Inc. | 3 | $67 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
| Amgen | 3 | $51 |
| Alfasigma USA, Inc. | 3 | $50 |
| Acella Pharmaceuticals, LLC | 3 | $48 |
| Eisai Inc. | 2 | $35 |
| IBSA Pharma Inc. | 2 | $32 |
| Medtronic | 2 | $32 |
| Bausch Health US, LLC | 2 | $31 |
| Exact Sciences | 2 | $30 |
| Genentech USA, Inc. | 3 | $24 |
| Halozyme Inc | 1 | $22 |
| Mayne Pharma Commercial LLC | 1 | $20 |
| Vivus LLC | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| GSK | 1 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Exeltis, USA Inc. | 1 | $15 |
| Sunovion Pharmaceuticals Inc. | 1 | $15 |
| Clarus Therapeutics Inc. | 1 | $14 |
| Avanir Pharmaceuticals, Inc. | 1 | $14 |
| Abbott | 1 | $12 |
How this compares
$3,656 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 25 | $1,669 |
| Levothyroxine Sodium | 27 | $509 |
| Rosuvastatin Calcium | 18 | $297 |
| Ondansetron OdtOndansetron | 13 | $241 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 19 | $224 |
| Bupropion XlBupropion Hcl | 11 | $202 |
| Spironolactone | 17 | $168 |
| Gabapentin | 15 | $131 |
| Buspirone Hcl | 11 | $114 |
| Alprazolam | 19 | $88 |
| Trazodone Hcl | 12 | $86 |
| Hydroxyzine Hcl | 11 | $71 |
| Anastrozole | 14 | $41 |
| Hydrochlorothiazide | 19 | $39 |
Paid to pharmacies, not to this prescriber.
Other family in Prosper
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.